Clinical characteristics of 330 patients with community-acquired pneumonia admitted to ICUs or general wards
| Clinical parameters | ICU | General Wards | p Value* |
|---|---|---|---|
| N | 83 | 247 | |
| Age (years), median (range) | 68 (20–93) | 63 (18–94) | 0.06 |
| Men, n (%) | 39 (47.0) | 138 (55.9) | 0.2 |
| Hospital stay (days), median/n (range) | 116/80 (24–196) | 6/195 (1–61) | <0.001 |
| Comorbidity, n (%) | N=81 | N=233 | |
| Any | 56 (69.1) | 118 (50.6) | 0.006 |
| Diabetes mellitus | 19 (23.5) | 66 (28.3) | 0.4 |
| Chronic obstructive pulmonary dis. | 14 (17.3) | 76 (32.6) | 0.01 |
| Asthma | 1 (1.2) | 26 (11.2) | 0.01 |
| Cardiac failure | 22 (27.2) | 55 (23.6) | 0.6 |
| Liver damage | 7 (8.7) | 13 (5.6) | 0.7 |
| Renal disease | 5 (6.2) | 8 (3.4) | 0.7 |
| Antibiotics prior to admission, n/N (%) | 17/82 (20.7) | 47/233 (20.2) | 0.9 |
| Infectious agent detected, n (%) | |||
| Virus | 17 (20.5) | 58 (23.5) | 0.6 |
| Bacteria | 19 (22.9) | 63 (25.5) | 0.7 |
| Virus–bacteria coinfection | 17 (20.5) | 37 (14.9) | 0.3 |
| Negative | 30 (36.1) | 89 (36.0) | 0.9 |
| Mental confusion, n/N (%) | 45/82 (54.9) | 32/230 (13.9) | <0.001 |
| Pleural effusion, n/N (%) | 25/81 (30.9) | 37/228 (16.2) | 0.008 |
| Hypotension, n/N (%) | 40/80 (50.0) | 19/231 (8.2) | <0.001 |
| Respiratory rate, median/n (range) | 28/79 (18–36) | 24/168 (16–40) | <0.001 |
| Pulse, median/n (range) | 105/81 (73–142) | 93/226 (41–180) | <0.001 |
| Systolic pressure (mm Hg), median/n (range) | 110/79 (68–213) | 122/174 (75–195) | 0.006 |
| Diastolic pressure (mm Hg), median/n (range) | 60/78 (26–133) | 70/174 (43–97) | <0.001 |
| Chest Rx multilobar involvement, n/N (%) | 41/81 (50.6) | 65/229 (28.9) | <0.001 |
| Fine score, n (%) | N=83 | N=247 | |
| 1 | 5 (6.0) | 64 (25.9) | <0.001 |
| 2 | 6 (7.2) | 59 (23.9) | <0.001 |
| 3 | 15 (18.1) | 53 (21.5) | 0.6 |
| 4 | 24 (28.9) | 62 (25.1) | 0.6 |
| 5 | 33 (39.8) | 9 (3.6) | <0.001 |
| Blood urea (mg/dL), median/n (range) | 21/79 (8–116) | 18/219 (6–75) | <0.001 |
| Chest Rx progression, n/N (%) | 13/80 (16.3) | 7/231 (3.0) | <0.001 |
| Hepatic failure, n/N (%) | 8/80 (10.0) | 1/231 (0.4) | <0.001 |
| Respiratory failure, n/N (%) | 29/80 (36.3) | 24/232 (10.3) | <0.001 |
| Shock, n/N (%) | 27/80 (33.8) | 3/231 (1.3) | <0.001 |
| Death during hospitalisation and until 30 days post discharge, n/N (%) | 17/83 (20.5) | 9/247 (3.6) | <0.001 |
Santiago, Chile, 2005–2007.
ICU, intensive care unit.